Zhaonian Hao
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 2
- SARS-CoV-2 and COVID-19 Research 1
- Modeling and Simulation top 10%
-
- Immune Cell Function and Interaction 2
-
- Cancer Immunotherapy and Biomarkers 3
-
- Glioma Diagnosis and Treatment 5
- Virus-based gene therapy research 1
-
- Cancer, Hypoxia, and Metabolism 2
-
- Radiomics and Machine Learning in Medical Imaging 1
- Journals
- SHILAP Revista de lepidopterología (1 paper)Medicine (1 paper)Metabolism (1 paper)
- Partner nations
- ChinaBelarusUnited States
In The Last Decade
Zhaonian Hao
11 papers receiving 444 citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Infectious Diseases 142
- Modeling and Simulation 31
- Immunology 109
- Oncology 130
- Genetics 40
Countries citing papers authored by Zhaonian Hao
This map shows the geographic impact of Zhaonian Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaonian Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaonian Hao more than expected).
Fields of papers citing papers by Zhaonian Hao
This network shows the impact of papers produced by Zhaonian Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaonian Hao. The network helps show where Zhaonian Hao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhaonian Hao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 0 | |
| 4 | 2022 | 14 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 3 | |
| 7 | 2021 | 65 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 2 | |
| 10 | 2020 | 75 | |
| 11 | Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertensionbreakdown → | 2020 | 233 |
| 12 | 2019 | 40 |
About Zhaonian Hao
Zhaonian Hao is a scholar working on Genetics, Modeling and Simulation and Cancer Research, having authored 12 papers that have together received 444 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), COVID-19 Clinical Research Studies (2 papers), Immune Cell Function and Interaction (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Infectious Diseases (142 citations), Modeling and Simulation (31 citations) and Immunology (109 citations). Zhaonian Hao has collaborated with scholars based in China, Belarus and United States. Frequent co-authors include Ruyuan Li, Zhiqiang Han, Zhenya Hong, Dongsheng Guo, Shufen Li, Yan Wu, Leike Zhang, Runming Jin, Hao Li and Hao‐Long Zeng. Their work appears in journals such as SHILAP Revista de lepidopterología, Medicine and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.